Citation Impact

Citing Papers

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities
2022 Standout
Astrocytes: biology and pathology
2009 Standout
Immune tolerance: What is unique about the liver
2009
Downregulation of miR-200a Induces EMT Phenotypes and CSC-like Signatures through Targeting the β-catenin Pathway in Hepatic Oval Cells
2013
Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
2016
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Ideal Cardiovascular Health in the Oldest-Old and Centenarians and Its Association With Disability and Health-Related Quality of Life
2021
Vascular disorders of the liver # †
2008 Standout
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Mitochondria and cancer
2012 Standout
Deficiency of canonical Wnt/β‐catenin signalling in hepatic dendritic cells triggers autoimmune hepatitis
2019
Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling"
2010

Works of Xiaoping Chen being referenced

Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection
2009
Daintain/AIF‐1 promotes breast cancer proliferation via activation of the NF‐κB/cyclin D1 pathway and facilitates tumor growth
2008
Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo
2011
Management of severe Budd-Chiari syndrome: report of 147 cases.
2004
Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease
2018
Cohort Profile: The China Hainan Centenarian Cohort Study (CHCCS)
2018
Rankless by CCL
2026